St. Jude Medical, Inc. was acquired by St. Jude Medical, LLC. St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorder worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. The company offers traditional cardiac rhythm management products comprising single and dual chamber pacemakers and single and dual chamber implantable cardioverter-defibrillators (ICDs); heart failure products, such as bi-ventricular cardiac resynchronization therapy pacemakers and ICDs, ventricular assist devices, and the CardioMEMS HF system; atrial fibrillation consisting of electrophysiology introducers and catheters, left atrial appendage closure products, advanced cardiac mapping, navigation and recording systems, and ablation systems. It also provides heart valve replacement and repair devices; patent foramen ovale closure devices, structural heart defect devices, active vascular closure devices, compression assist devices, pressure measurement guidewires, diagnostic coronary imaging technology percutaneous catheter introducers, diagnostic guidewires, percutaneous heart pumps, renal denervation technology, and vascular plugs; and spinal cord stimulation, dorsal root ganglion stimulation, and radiofrequency ablation products for the treatment of chronic pain, as well as deep brain stimulation for the treatment of movement disorders. The company sells its products to clinics and hospitals through direct sales force and independent distributors. St. Jude Medical, Inc. was founded in 1976 and is headquartered in St. Paul, Minnesota.